120 related articles for article (PubMed ID: 15617746)
1. Detection of fibrin generation alterations in dogs with haemangiosarcoma using resonance thrombography.
Mischke R; Wohlsein P; Schoon HA
Thromb Res; 2005; 115(3):229-38. PubMed ID: 15617746
[TBL] [Abstract][Full Text] [Related]
2. Detection of anticoagulant activities of isolated canine fibrinogen degradation products X, Y, D and E using resonance thrombography.
Mischke R; Wolling H; Nolte I
Blood Coagul Fibrinolysis; 2004 Jan; 15(1):81-8. PubMed ID: 15166948
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the global haemostatic function test 'resonance thrombography' in spontaneously traumatised dogs.
Mischke R
Pathophysiol Haemost Thromb; 2003 Jul-2004 Aug; 33(4):214-20. PubMed ID: 15583452
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different methods to measure fibrinogen concentration in canine plasma with respect to their sensitivity towards the fibrinogen degradation products X, Y and D.
Mischke R; Menzel D; Wolling H
Haemostasis; 2000; 30(3):131-8. PubMed ID: 11014963
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of kits for the detection of fibrin(ogen) degradation products in dogs.
Stokol T; Brooks M; Erb H; Mauldin GE
J Vet Intern Med; 1999; 13(5):478-84. PubMed ID: 10499733
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong.
Chan JC; Kwok MM; Cockram CS; Prematilleke MN; Tomlinson B; Critchley JA
Singapore Med J; 1993 Apr; 34(2):145-7. PubMed ID: 8266156
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.
Guo F; Liu J; Wang C; Liu N; Lu P
Biochem Biophys Res Commun; 2009 Dec; 390(3):942-6. PubMed ID: 19852936
[TBL] [Abstract][Full Text] [Related]
8. Effect of internal hemorrhage on fibrin(ogen) degradation products in canine blood.
McCaw DL; Jergens AE; Turrentine MA; Johnson GS
Am J Vet Res; 1986 Jul; 47(7):1620-1. PubMed ID: 3740635
[TBL] [Abstract][Full Text] [Related]
9. [Disseminated intravascular coagulation and hyperfibrinolysis in dogs with metastasizing mammary carcinoma].
Mischke R; Wohlsein P; Busse L; Pohlenz J
Schweiz Arch Tierheilkd; 1998; 140(12):497-505. PubMed ID: 9863356
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
Arnesen H
J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
[No Abstract] [Full Text] [Related]
11. [Sensitivity of resonance thrombograms in thrombocytopenia of dogs].
Mischke R; Adamik A
Berl Munch Tierarztl Wochenschr; 1998; 111(7-8):302-5. PubMed ID: 9741188
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
13. Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma.
Mischke R; Wolling H
Haemostasis; 2000; 30(3):123-30. PubMed ID: 11014962
[TBL] [Abstract][Full Text] [Related]
14. Serum and plasma latex agglutination tests for detection of fibrin(ogen) degradation products in clinically ill dogs.
Boisvert AM; Swenson CL; Haines CJ
Vet Clin Pathol; 2001; 30(3):133-136. PubMed ID: 12024312
[TBL] [Abstract][Full Text] [Related]
15. [Changes in hemostasis of dogs with acute lymphoblastic leukemia].
Mischke R; Freund M; Leinemann-Fink T; Eisenberger B; Casper J; Nolte I
Berl Munch Tierarztl Wochenschr; 1998 Feb; 111(2):53-9. PubMed ID: 9513298
[TBL] [Abstract][Full Text] [Related]
16. Biological behavior of higher molecular weight products of fibrinolysis.
Chang ML; Bang NU
J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
Widström O; Kockum C; Nilsson BS
Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
[TBL] [Abstract][Full Text] [Related]
18. Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH.
Godal HC; Hamborg T
Scand J Haematol; 1984 Jan; 32(1):46-8. PubMed ID: 6695150
[TBL] [Abstract][Full Text] [Related]
19. Unreliability of current serum fibrin degradation product (FDP) assays.
Gaffney PJ; Perry MJ
Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of latex agglutination tests for fibrin-fibrinogen degradation products in the forensic identification of menstrual blood.
Akutsu T; Watanabe K; Motani H; Iwase H; Sakurada K
Leg Med (Tokyo); 2012 Jan; 14(1):51-4. PubMed ID: 22189168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
